SynthesisEuropean urology2014

Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer.

Benjamin A Gartrell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.